Essex Bio-Technology's quarterly market cap
declined
from Jun. 2023 (HK$2,048 Mil) to Dec. 2023 (HK$1,413 Mil) and
declined
from Dec. 2023 (HK$1,413 Mil) to Jun. 2024 (HK$1,373 Mil).
Essex Bio-Technology's annual market cap
declined
from Dec. 2021 (HK$2,849 Mil) to Dec. 2022 (HK$2,401 Mil) and
declined
from Dec. 2022 (HK$2,401 Mil) to Dec. 2023 (HK$1,413 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Essex Bio-Technology's Enterprise Value for Today is HK$1,940 Mil.
Essex Bio-Technology Market Cap Historical Data
The historical data trend for Essex Bio-Technology's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Essex Bio-Technology's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Essex Bio-Technology's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's Market Cap distribution charts can be found below:
* The bar in red indicates where Essex Bio-Technology's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Essex Bio-Technology's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Essex Bio-Technology (HKSE:01061) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Essex Bio-Technology Market Cap Related Terms
Thank you for viewing the detailed overview of Essex Bio-Technology's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01061 has been successfully added to your 